Literature DB >> 16306238

Predicting Alzheimer's disease in the Baltimore longitudinal study of aging.

Alan B Zonderman1.   

Abstract

Longitudinal studies offer opportunities for studying children whose parents have Alzheimer's disease. The Baltimore Longitudinal Study of Aging (BLSA) has examined adult cognitive performance but has not systematically recruited participants' children. We initiated studies of dementia in the 1980s. This work suggested that hormone replacement and use of nonsteroidal anti-inflammatory drugs reduced the risk of Alzheimer's disease and that risk for Alzheimer's disease could be predicted from cognitive performance as many as 20 years prior to its onset. More recently, we showed that premorbid levels of free testosterone were lower in men who developed Alzheimer's disease and premorbid depressive symptomatology was a risk for Alzheimer's disease in men but not women as many as 6 years before the onset of dementia. Participants in the BLSA include family members with a variety of degrees of relationship, but there is no systematic effort to collect data from relatives of participants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306238      PMCID: PMC1350725          DOI: 10.1177/0891988705281863

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  14 in total

Review 1.  Two-wave longitudinal findings from the Berlin aging study: introduction to a collection of articles.

Authors:  Jacqui Smith; Ineke Maas; Karl Ulrich Mayer; Hanfried Helmchen; Elisabeth Steinhagen-Thiessen; Paul B Baltes
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2002-11       Impact factor: 4.077

2.  Visual memory predicts Alzheimer's disease more than a decade before diagnosis.

Authors:  C H Kawas; M M Corrada; R Brookmeyer; A Morrison; S M Resnick; A B Zonderman; D Arenberg
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

Review 3.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

4.  A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging.

Authors:  C Kawas; S Resnick; A Morrison; R Brookmeyer; M Corrada; A Zonderman; C Bacal; D D Lingle; E Metter
Journal:  Neurology       Date:  1997-06       Impact factor: 9.910

5.  Risk of Alzheimer's disease and duration of NSAID use.

Authors:  W F Stewart; C Kawas; M Corrada; E J Metter
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

6.  Established populations for epidemiologic studies of the elderly: study design and methodology.

Authors:  J Cornoni-Huntley; A M Ostfeld; J O Taylor; R B Wallace; D Blazer; L F Berkman; D A Evans; F J Kohout; J H Lemke; P A Scherr
Journal:  Aging (Milano)       Date:  1993-02

7.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

8.  Free testosterone and risk for Alzheimer disease in older men.

Authors:  S D Moffat; A B Zonderman; E J Metter; C Kawas; M R Blackman; S M Harman; S M Resnick
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

9.  Assessing the risk of Alzheimer's disease in first-degree relatives of Alzheimer's disease cases.

Authors:  A E Korten; A F Jorm; A S Henderson; G A Broe; H Creasey; E McCusker
Journal:  Psychol Med       Date:  1993-11       Impact factor: 7.723

10.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

View more
  5 in total

Review 1.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

Review 2.  Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.

Authors:  Huan Cai; Wei-na Cong; Sunggoan Ji; Sarah Rothman; Stuart Maudsley; Bronwen Martin
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

3.  Hormone therapy and the decreased risk of dementia in women with depression: a population-based cohort study.

Authors:  Hyewon Kim; Juhwan Yoo; Kyungdo Han; Dong-Yun Lee; Maurizio Fava; David Mischoulon; Hong Jin Jeon
Journal:  Alzheimers Res Ther       Date:  2022-06-16       Impact factor: 8.823

Review 4.  Androgen-deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire?

Authors:  Deaglan J McHugh; James C Root; Christian J Nelson; Michael J Morris
Journal:  Cancer       Date:  2018-01-16       Impact factor: 6.860

Review 5.  Thyroid hormone: sex-dependent role in nervous system regulation and disease.

Authors:  Shounak Baksi; Ajay Pradhan
Journal:  Biol Sex Differ       Date:  2021-03-08       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.